Use of exogenous hormones and risk of temporomandibular disorder pain

Pain

Volumn 69, Issue 1-2, 1997, Pages 153-160

  LeResche, Linda ^a   Saunders, Kathleen ^b   Von Korff, Michael R ^b   Barlow, William ^b   Dworkin, Samuel F ^a,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b CENTER FOR HEALTH STUDIES   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Exogenous hormones; Hormone replacement therapy; Oral contraceptives; Temporomandibular

Indexed keywords

CONJUGATED ESTROGEN; CONTRACEPTIVE AGENT; ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FACE PAIN; FEMALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; OROFACIAL PAIN; OTALGIA; POSTMENOPAUSE; PRIORITY JOURNAL; TEMPOROMANDIBULAR JOINT DISORDER;

ADULT; CASE-CONTROL STUDIES; CONTRACEPTIVES, ORAL, HORMONAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGEN REPLACEMENT THERAPY; FEMALE; HORMONES; HUMANS; MIDDLE AGED; POSTMENOPAUSE; PROGESTINS; REGISTRIES; REGRESSION ANALYSIS; RISK; TEMPOROMANDIBULAR JOINT DISORDERS;

EID: 0031044733     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(96)03230-7     Document Type: Article

References (31)

1. Abubaker, A.O., John, F., Sotereanos, G.C., Patterson, G. and Jenosky, J., Prevalence of female sex hormone use by female TMJ patients, J. Dent. Res., 71 (Special issue) (1992) 259.
2. Abubaker, A.O., Raslan, W.F. and Sotereanos, G.C., Estrogen and progesterone receptors in temporomandibular joint disc of symptomatic and asymptomatic persons: A preliminary study, J. Oral Maxillofac. Surg., 51 (1993) 1096-1100.
3. Aufdemorte, T.B., Van Sickels, J.E., Dolwick, M.F., Sheridan, P.J., Holt, G.R., Aragon, S.B. and Gates, G.A., Estrogen receptors in the temporomandibular joint of the baboon (Papio cynocephalus): An autoradiographic study, Oral Surg. Oral Med. Oral Pathol., 61 (1986) 307-314.
4. Berkley, K.J., Sex and chronobiology: Opportunities for a focus on the positive, IASP Newsletter, Jan/Feb (1993) 2-5.
5. Bodnar, R.J., Romero, M. and Kramer, E., Organismic variables and pain inhibition: Roles of gender and aging, Brain Res. Bull., 21 (1988) 947-953.
6. Breslow, N.E. and Day, N.E., Statistical Methods in Cancer Research Volume 1: The Design and Analysis of Case-Control Studies, IARC Publications, Lyons, France, 1980, pp. 248-279.
7. Campbell, J.H., Courey, M.S., Bourne, P. and Odziemiecs, C., Estrogen receptor analysis of human temporomandibular disc, J. Oral Maxillofac. Surg., 51 (1993) 1101-1105.
8. Carlsson, G. and LeResche, L., Epidemiology of temporomandibular disorders. In: B. Sessle, P. Bryant and R. Dionne (Eds.), Progress in Pain Research and Management, IASP Press, Seattle, 1995, pp. 211-226.
9. Dworkin, S.F., Huggins, K.H., LeResche, L., Von Korff, M., Howard, J., Truelove, E. and Sommers, E., Epidemiology of signs and symptoms in temporomandibular disorders: Clinical signs in cases and controls, J. Am. Dent. Assoc., 120 (1990) 273-281.
10. Dworkin, S.F. and LeResche, L., (Eds.), Research diagnostic criteria for temporomandibular disorders, J. Craniomandib. Disord. Facial Oral Pain, 6 (1992) 301-355.
11. Haskin, C.L., Milam, S.B. and Cameron, I.L., Pathogenesis of degenerative joint disease in the human temporomandibular joint, Crit. Rev. Oral Biol. Med., 6 (1995) 248-277.
12. Goulet, J.-P., Lavigne, G.J. and Lund, J.P., Jaw pain prevalence among French-speaking Canadians in Quebec and related symptoms of temporomandibular disorders, J. Dent. Res., 74 (1995) 1738-1744.
13. Jick, H., Experiences of the Boston Collaborative Drug Surveillance Program. In: W.A. Gouveia (Ed.), Clinical Pharmacy and Clinical Pharmacology, North-Holland Publ., Amsterdam, 1976, pp. 179-182.
14. LeResche, L., Saunders, K., Barlow, W., Von Korff, M. and Dworkin, S.F., Does oral contraceptive use increase the risk of temporomandibular disorder (TMD) pain? Abstracts, 7th World Congress on Pain, Abstr. 786 (1993) 294.
15. Lipton, J.A., Ship, J.A. and Larach-Robinson, D., Estimated prevalence and distribution of reported orofacial pain in the United States, J. Am. Dent. Assoc., 124 (1993) 115-121.
16. Locker, D. and Slade, G., Prevalence of symptoms associated with temporomandibular disorders in a Canadian population, Community Dent. Oral Epidemiol., 16 (1988) 310-313.
17. Marbach, J.J., Lennon, M.C. and Dohrenwend, B.P., Candidate risk factors for temporomandibular pain and dysfunction syndrome: Psychosocial, health behavior, physical illness and injury, Pain, 34 (1988) 139-151.
18. Marcus, D.A., Interrelationships of neurochemicals, estrogen, and recurring headache, Pain, 62 (1995) 129-139.
19. Milam, S.B., Aufdemorte, T.B., Sheridan, P.J., Triplett, R.G., Van Sickels, J.E. and Holt, G.R., Sexual dimorphism in the distribution of estrogen receptors in the temporomandibular joint complex of the baboon, Oral Surg. Oral Med. Oral Pathol., 64 (1987) 527-532.
20. Milam, S.B., Articular disk displacements and degenerative temporomandibular joint disease. In: B.J. Sessle, P.S. Bryant and R.A. Dionne (Eds.), Temporomandibular Disorders and Related Pain Conditions, IASP Press, Seattle, 1995, pp. 89-112.
21. Mogil, J.S., Sternberg, W.F., Kest, B., Marek, P. and Liebeskind, J.C., Sex differences in the antagonism of swim stress-induced analgesia: Effects of gonadectomy and estrogen replacement, Pain, 53 (1993) 17-25.
22. SAS Institute Inc., SAS User's Guide: Statistics, Version 6 (4th edn.), SAS Institute Inc., Cary, NC, 1989.
23. Saunders, K.W., Stergachis, A. and Von Korff, M., Group Health Cooperative of Puget Sound. In: B.L. Strom (Ed.), Pharmacoepidemiology (2nd edn.), John Wiley and Sons, New York, 1994.
24. Schipper, H.M., Neurology of sex steroids and oral contraceptives, Neurol. Clin., 4 (1986) 721-751.
25. Silberstein, S.D. and Merriam, G.R., Estrogens, progestins, and headache, Neurology, 41 (1991) 786-793.
26. Spagnoli, D. and Kent, J.N., Multicenter evaluation of temporomandibular joint Proplast-Teflon disk implant, Oral Surg. Oral Med. Oral Pathol., 74 (1992) 411-421.
27. Sternberg, W.F., Mogil, J.S., Kest, B., Page, G.G., Leong, Y., Yam, V. and Liebeskind, J.C., Neonatal testosterone exposure influences neurochemistry of non-opioid swim stress-induced analgesia in adult mice, Pain, 63 (1995) 321-326.
28. Von Korff, M., Dworkin, S.F., LeResche, L. and Kruger, A., An epidemiologic comparison of pain complaints, Pain, 32 (1988) 173-183.
29. Von Korff, M., Dworkin, S.F. and LeResche, L., Graded chronic pain status: An epidemiologic evaluation, Pain, 40 (1990) 279-291.
30. Von Korff, M., Wagner, E.H., Dworkin, S.F. and Saunders, K.W. Chronic pain and use of ambulatory health care. Psychosom. Med., 53 (1991) 61-79.
31. Westling, L., Temporomandibular joint dysfunction and systemic joint laxity, Swed. Dent. J., 81 (Suppl.) (1992) 1-79.